WallStreetZenWallStreetZen

NASDAQ: INKT
Mink Therapeutics Inc Stock Ownership - Who owns Mink Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Mink Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Robert Peter KadlecDirector2025-06-021,883$7.17
$13.50kBuy
Ulf WiinbergDirector2025-06-021,953$7.17
$14.00kBuy
Brian CorveseDirector2025-06-022,494$7.17
$17.88kBuy
Peter BehnerDirector2025-06-022,267$7.17
$16.25kBuy
Barbara RyanDirector2025-06-022,476$7.17
$17.75kBuy
Robert Peter KadlecDirector2025-03-031,536$8.79
$13.50kBuy
Peter BehnerDirector2025-03-031,849$8.79
$16.25kBuy
Brian CorveseDirector2025-03-032,033$8.79
$17.87kBuy
Barbara RyanDirector2025-03-032,019$8.79
$17.75kBuy
Ulf WiinbergDirector2025-03-031,593$8.79
$14.00kBuy

1 of 2

INKT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INKT insiders and whales buy or sell their stock.

INKT Shareholders

What type of owners hold Mink Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Agenus Inc546.28%21,772,863$506.22MInsider
Garo H. Armen49.34%1,966,400$45.72MInsider
Jennifer Buell5.83%232,165$5.40MInsider
Christine M. Klaskin1.40%55,660$1.29MInsider
Brian Corvese1.18%47,151$1.10MInsider
Ulf Wiinberg1.15%45,790$1.06MInsider
John Baldoni1.03%41,193$957.74kInsider
Dijk Marcus Antonius Van0.69%27,363$636.19kInsider
Vanguard Group Inc0.60%23,744$552.05kInstitution
Barbara Ryan0.49%19,524$453.93kInsider

1 of 3

INKT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INKT0.26%99.74%Net BuyingNet Buying
NAUT40.37%59.63%Net BuyingNet Buying
ENTX22.49%16.17%Net Buying
XBIT14.69%45.12%
VANI3.32%96.68%Net BuyingNet Buying
View Top Biotech Stocks

Mink Therapeutics Stock Ownership FAQ

Who owns Mink Therapeutics?

Mink Therapeutics (NASDAQ: INKT) is owned by 1.58% institutional shareholders, 607.94% Mink Therapeutics insiders, and 0.00% retail investors. Agenus Inc is the largest individual Mink Therapeutics shareholder, owning 21.77M shares representing 546.28% of the company. Agenus Inc's Mink Therapeutics shares are currently valued at $506.22M.

If you're new to stock investing, here's how to buy Mink Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.